Center Autonomic Disorders Inc is categorized under Family Practice Doctors in Pensacola, FL and active since 2012.
Center Autonomic Disorders Inc was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Charles R Thompson at the company’s single location by writing to 6706 North 9th Avenue, Pensacola, Florida FL 32504 or by phoning (850) 476-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Center Autonomic Disorders Inc |
Contact Person: | Charles R Thompson |
Address: | 6706 North 9th Avenue, Pensacola, Florida 32504 |
Phone Number: | (850) 476-8200 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Center Autonomic Disorders Inc was started in 2012 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Charles R Thompson for inquiries that concern Center Autonomic Disorders Inc by calling the company number (850) 476-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Center Autonomic Disorders Inc can be found at the coordinates 30.498693,-87.186409 as well as the street address 6706 North 9th Avenue in Pensacola, Florida 32504.
For its online presence, you may visit Center Autonomic Disorders Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.